Related Experiment Video
Updated: Jun 3, 2025

05:39
Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
Published on: April 5, 2024
759
Exploring the Metabolic Impact of FLASH Radiotherapy
Febe Geirnaert1, Lisa Kerkhove1, Pierre Montay-Gruel2,3
1Department of Radiotherapy, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, 1090 Brussels, Belgium.
Cancers
|January 11, 2025
Summary
FLASH radiotherapy (FLASH RT) uses ultrahigh dose rates (UHDRs) to potentially reduce normal tissue damage while controlling tumors. Research suggests altered metabolic and cellular responses, particularly in reactive oxygen species and mitochondria, underlie this promising cancer treatment effect.
Area of Science:
- Oncology
- Radiation Oncology
- Molecular Biology
Background:
- Conventional radiotherapy (CRT) faces challenges with normal tissue toxicity.
- FLASH radiotherapy (FLASH RT) delivers ultrahigh dose rates (UHDRs), offering a potentially wider therapeutic window.
- The underlying mechanisms of the FLASH effect, particularly metabolic and cellular responses, require further elucidation.
Purpose of the Study:
- To review and synthesize current research on the metabolic and cellular responses to FLASH RT compared to CRT.
- To explore the differential impact of FLASH RT on normal versus tumor tissues.
- To identify potential mechanisms contributing to the observed FLASH effect.
Main Methods:
- Literature review of studies comparing FLASH RT and CRT.
- Focus on metabolic pathways, reactive oxygen species (ROS) dynamics, iron metabolism, lipid peroxidation, and mitochondrial function.
- Analysis of differential effects on normal and tumor tissues.
Main Results:
- FLASH RT may mitigate normal tissue damage through altered ROS dynamics, reducing oxidative stress.
- Distinct effects on iron metabolism and lipid peroxidation pathways compared to CRT observed.
- Evidence suggests FLASH RT preserves mitochondrial integrity and function, supporting normal tissue apoptosis and attenuating damage.
Conclusions:
- FLASH RT demonstrates potential for reduced normal tissue toxicity by influencing key metabolic and cellular pathways.
- Further research in complex biological systems is needed to fully understand FLASH RT's clinical potential.
- Targeting distinct metabolic pathways with FLASH RT could revolutionize cancer treatment and improve patient outcomes.

